Andelyn Biosciences, Inc., a cell and gene therapy CDMO, has partnered with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene therapies. The collaboration was established to facilitate the pathway to bring Ohio State’s investigational gene therapies for a multitude of neurological disorders, such as Parkinson’s, amyotrophic lateral sclerosis (ALS), and Huntington’s, from concept through to manufacturing for clinical trials. Princi...